Fungitell® Bulletins
2025
Fungitell® Bulletin v11i4 - October 2025
The Use Of (1→3)-β-D-Glucan Testing for Pneumocystis Pneumonia in HIV+ and HIV- Groups
Fungitell® Bulletin v11i3 - July 2025
BG Analytics® Software Update Addition of Estimated pg/mL Values
Fungitell® Bulletin v11i2 - April 2025
(1→3)-β-D-Glucan as an Aid to the Diagnosis of Invasive Fungal Infections in HIV/AIDS Patients
Fungitell® Bulletin v11i1 - January 2025
Serum (1→3)-β-D-Glucan in critically ill patients and the intensive care unit
2024
Fungitell® Bulletin v10i4 - September 2024
(1→3)-β-D-Glucan and Coccidioidomycosis
2023
Fungitell® Bulletin v10i3 - August 2023
Candida Auris and (1→3)-β-D-Glucan
2022
Fungitell® Bulletin v10i2 - February 2022
Clostridium Difficile Infection and Candidemia: Prevalence and Clinical Impact
2021
Fungitell® Bulletin v10i1 - December 2021
Hepatic clearance of (1→3)-β-Glucan: Effects upon circulating BDG titer
Fungitell® Bulletin v9i4 - August 2021
Invasive fungal infection in COVID-19: Prevalence and Diagnostic Challenges
2020
Fungitell® Bulletin v9i3 - November 2020
From Serum to Result in One Hour: Fungitell STAT® Explained
Fungitell® Bulletin v9i2 - October 2020
Application of Fungitell® in Fungal Chorioretinitis and Endophthalmitis
Fungitell® Bulletin v9i1 - April 2020
Influence Of (1→3)-β-Glucan Structure Upon Reactivity